172 related articles for article (PubMed ID: 36386677)
1. Comparison of molecular and MALDI-TOF MS identification and antifungal susceptibility of clinical
Guo P; Chen J; Tan Y; Xia L; Zhang W; Li X; Jiang Y; Li R; Chen C; Liao K; Peng Y
Front Microbiol; 2022; 13():992582. PubMed ID: 36386677
[TBL] [Abstract][Full Text] [Related]
2. Molecular and MALDI-ToF MS differentiation and antifungal susceptibility of prevalent clinical Fusarium species in China.
Song Y; Liu X; Yang Z; Meng X; Xue R; Yu J; Al-Hatmi AMS; de Hoog GS; Li R
Mycoses; 2021 Oct; 64(10):1261-1271. PubMed ID: 34173979
[TBL] [Abstract][Full Text] [Related]
3. Molecular Characterization and Antifungal Susceptibility of Clinical
Herkert PF; Al-Hatmi AMS; de Oliveira Salvador GL; Muro MD; Pinheiro RL; Nucci M; Queiroz-Telles F; de Hoog GS; Meis JF
Front Microbiol; 2019; 10():737. PubMed ID: 31024507
[No Abstract] [Full Text] [Related]
4. International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method.
Espinel-Ingroff A; Colombo AL; Cordoba S; Dufresne PJ; Fuller J; Ghannoum M; Gonzalez GM; Guarro J; Kidd SE; Meis JF; Melhem TM; Pelaez T; Pfaller MA; Szeszs MW; Takahaschi JP; Tortorano AM; Wiederhold NP; Turnidge J
Antimicrob Agents Chemother; 2016 Feb; 60(2):1079-84. PubMed ID: 26643334
[TBL] [Abstract][Full Text] [Related]
5. Identification by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Antifungal Susceptibility Testing of Non-
Li Y; Wang H; Hou X; Huang JJ; Wang PC; Xu YC
Front Microbiol; 2020; 11():922. PubMed ID: 32582045
[TBL] [Abstract][Full Text] [Related]
6. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe.
Tortorano AM; Prigitano A; Esposto MC; Arsic Arsenijevic V; Kolarovic J; Ivanovic D; Paripovic L; Klingspor L; Nordøy I; Hamal P; Arikan Akdagli S; Ossi C; Grancini A; Cavanna C; Lo Cascio G; Scarparo C; Candoni A; Caira M; Drogari Apiranthitou M;
Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1623-30. PubMed ID: 24791951
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
[TBL] [Abstract][Full Text] [Related]
8. Fusarium Keratitis From a Comprehensive Eye Health Care Facility in South India: Molecular Characterization by MALDI-TOF Versus Polymerase Chain Reaction Sequencing, Species Complex Distribution, and Clinical Correlation.
Bagga B; Das S; Tawde Y; Singh S; Shaw T; Sharma S; Ghosh A
Cornea; 2023 Sep; 42(9):1150-1162. PubMed ID: 37267470
[TBL] [Abstract][Full Text] [Related]
9. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
[TBL] [Abstract][Full Text] [Related]
10. [Detection of virulence factors and antifungal susceptibilities of Fusarium strains isolated from keratitis cases].
Çuhadar T; Karabıçak N; Özdil T; Özgür D; Otağ F; Hızel K; Kalkancı A
Mikrobiyol Bul; 2018 Jul; 52(3):247-258. PubMed ID: 30156511
[TBL] [Abstract][Full Text] [Related]
11. Fusarium keratitis in South India: causative agents, their antifungal susceptibilities and a rapid identification method for the Fusarium solani species complex.
Homa M; Shobana CS; Singh YR; Manikandan P; Selvam KP; Kredics L; Narendran V; Vágvölgyi C; Galgóczy L
Mycoses; 2013 Sep; 56(5):501-11. PubMed ID: 23437826
[TBL] [Abstract][Full Text] [Related]
12. Phylogenetic Diversity and In Vitro Susceptibility Profiles of Human Pathogenic Members of the Fusarium fujikuroi Species Complex Isolated from South India.
Tupaki-Sreepurna A; Thanneru V; Natarajan S; Sharma S; Gopi A; Sundaram M; Kindo AJ
Mycopathologia; 2018 Jun; 183(3):529-540. PubMed ID: 29445920
[TBL] [Abstract][Full Text] [Related]
13. [Molecular identification and in vitro susceptibility of Fusarium from fungal keratitis in central China].
Sun S; Lyu Q; Han L; Ma Q; Hu H; He S; Tao S; Zhang J; Zhang H; Wang L
Zhonghua Yan Ke Za Zhi; 2015 Sep; 51(9):660-7. PubMed ID: 26693650
[TBL] [Abstract][Full Text] [Related]
14. MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of
Fang L; Liu M; Huang C; Ma X; Zheng Y; Wu W; Guo J; Huang J; Xu H
Infect Drug Resist; 2022; 15():3449-3457. PubMed ID: 35800121
[TBL] [Abstract][Full Text] [Related]
15. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
Badali H; Cañete-Gibas C; Patterson H; Sanders C; Mermella B; Garcia V; Mele J; Fan H; Wiederhold NP
Mycoses; 2021 Jul; 64(7):748-752. PubMed ID: 33755988
[TBL] [Abstract][Full Text] [Related]
17. Rapid identification of clinical members of Fusarium fujikuroi complex using MALDI-TOF MS.
Al-Hatmi AM; Normand AC; van Diepeningen AD; Hendrickx M; de Hoog GS; Piarroux R
Future Microbiol; 2015; 10(12):1939-52. PubMed ID: 26610019
[TBL] [Abstract][Full Text] [Related]
18. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH
J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
[TBL] [Abstract][Full Text] [Related]
19. First Comprehensive Report of Clinical
Paziani MH; Tonani Carvalho L; Carvalho Melhem MS; Gottardo de Almeida MT; Nadaletto Bonifácio da Silva ME; Martinez R; Santos C; Kress MRVZ
Microorganisms; 2019 Dec; 8(1):. PubMed ID: 31906188
[TBL] [Abstract][Full Text] [Related]
20. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study.
Wang H; Xiao M; Kong F; Chen S; Dou HT; Sorrell T; Li RY; Xu YC
J Clin Microbiol; 2011 May; 49(5):1890-8. PubMed ID: 21389150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
